Production of hantavirus Puumala nucleocapsid protein in Saccharomyces cerevisiae for vaccine and diagnostics

被引:16
作者
Antoniukas, L.
Grammel, H.
Reichl, U.
机构
[1] Max Planck Inst Dynam Complex Tech Syst, D-39106 Magdeburg, Germany
[2] Univ Magdeburg, D-39106 Magdeburg, Germany
[3] Inst Biotechnol EV, LT-02241 Vilnius, Lithuania
关键词
Saccharomyces cerevisiae; fed-batch cultivation; GAL10; promoter; hantavirus Puumala nucleocapsid (N) protein;
D O I
10.1016/j.jbiotec.2005.12.028
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The production of hantavirus Puumala nucleocapsid (N) protein for potential applications as a vaccine and for diagnostic purposes was investigated with Saccharomyces cerevisiae as a recombinant host. The N protein gene and the hexahistidine tagged N (h-N) protein gene were expressed intracellular from a 2-mu m plasmid vectors under the control of a fused galactose inducible GAL10-PYK promoter. For monitoring the recombinant gene expression, a h-N and a GFP fusion protein was used. Different cultivation strategies and growth media compositions were tested in shake flasks and a 51 bioreactor. When using defined YNB growth medium, we found the biomass yield to be unsatisfactorily low. Higher concentrated YNB medium, promoted cell growth but showed a pronounced inhibitory effect on heterologous gene expression. This phenomenon could not be attributed to plasmid losses, as we could demonstrate high stability of the vector under the applied cultivation conditions. Supplementation of YNB medium with extracts of plant origin resulted in increased biomass yields with concomitant high expression levels of the recombinant gene. The modified medium was used for fed-batch cultivations where basic metabolic features as well as growth parameters were determined in addition to recombinant gene expression. The maximal volumetric yield of N protein was 316 mg1(-1), the respective yield of h-N protein was 284 mg1(-1). Our study provides a basis for large-scale production of hantavirus vaccines, which satisfies economic efficiency as well as biosafety regulations for human applications. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:347 / 362
页数:16
相关论文
共 47 条
[21]  
Johnson KM, 2001, CURR TOP MICROBIOL, V256, P1
[22]   High-level secretion of human alpha(1)-antitrypsin from Saccharomyces cerevisiae using inulinase signal sequence [J].
Kang, HA ;
Nam, SW ;
Kwon, KS ;
Chung, BH ;
Yu, MH .
JOURNAL OF BIOTECHNOLOGY, 1996, 48 (1-2) :15-24
[23]  
KASLOW DC, 1994, BIO-TECHNOL, V12, P494, DOI 10.1038/nbt0594-494
[24]   SIMPLE FED-BATCH TECHNIQUE FOR HIGH CELL-DENSITY CULTIVATION OF ESCHERICHIA-COLI [J].
KORZ, DJ ;
RINAS, U ;
HELLMUTH, K ;
SANDERS, EA ;
DECKWER, WD .
JOURNAL OF BIOTECHNOLOGY, 1995, 39 (01) :59-65
[25]   Functional expression, quantification and cellular localization of the Hxt2 hexose transporter of Saccharomyces cerevisiae tagged with the green fluorescent protein [J].
Kruckeberg, AL ;
Ye, L ;
Berden, JA ;
van Dam, K .
BIOCHEMICAL JOURNAL, 1999, 339 :299-307
[26]   Hantavirus infections and their prevention [J].
Krüger, DH ;
Ulrich, R ;
Lundkvist, Å .
MICROBES AND INFECTION, 2001, 3 (13) :1129-1144
[27]   Novel secretion system of recombinant Saccharomyces cerevisiae using an N-terminus residue of human IL-1β as secretion enhancer [J].
Lee, J ;
Choi, SI ;
Jang, JS ;
Jang, K ;
Moon, JW ;
Bae, CS ;
Yang, DS ;
Seong, BL .
BIOTECHNOLOGY PROGRESS, 1999, 15 (05) :884-890
[28]   INDUSTRIAL-PRODUCTION OF HETEROLOGOUS PROTEINS BY FED-BATCH CULTURES OF THE YEAST SACCHAROMYCES-CEREVISIAE [J].
MENDOZAVEGA, O ;
SABATIE, J ;
BROWN, SW .
FEMS MICROBIOLOGY REVIEWS, 1994, 15 (04) :369-410
[29]  
MendozaVega O, 1996, APPL MICROBIOL BIOT, V44, P624, DOI 10.1007/BF00172495
[30]   PRODUCTION OF RECOMBINANT HIRUDIN BY HIGH CELL-DENSITY FED-BATCH CULTIVATIONS OF A SACCHAROMYCES-CEREVISIAE STRAIN - PHYSIOLOGICAL CONSIDERATIONS DURING THE BIOPROCESS DESIGN [J].
MENDOZAVEGA, O ;
HEBERT, C ;
BROWN, SW .
JOURNAL OF BIOTECHNOLOGY, 1994, 32 (03) :249-259